Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease in the United States and can progress to cirrhosis or End Stage Liver Disease. Risk factors include being overweight or obese, having Type 2 Diabetes or pre-diabetes, abnormal cholesterol levels, high blood pressure, and obstructive sleep apnea.
With the right treatment plan, this disorder is reversible. Our trained specialists provide screenings for NAFLD, a workup for co-morbid conditions, and management through lifestyle interventions and therapies to reverse this disorder. Unlike others who typically rely on liver biopsy for diagnosing and staging of NAFLD, we stress the use of noninvasive techniques to screen and stratify patients.
Usually, this requires simple blood tests and use of imaging, such as ultrasound and tissue elastography to detect the presence, severity, and progression of NAFLD. Rarely do we recommend liver biopsy. If you have been diagnosed with fatty liver disease or nonalcoholic steatohepatitis (NASH), or are concerned a patient may have this disorder, consider a referral to the Fatty Liver Clinic.